• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Covid Media Misguidance: A Case Report Highlighting the Influence of Media on Patient Medication Decision Making.新冠疫情相关的媒体误导:一则病例报告凸显媒体对患者用药决策的影响
Innov Pharm. 2021 Jan 8;12(1). doi: 10.24926/iip.v12i1.3555. eCollection 2021.
2
A qualitative systematic review of internal and external influences on shared decision-making in all health care settings.对所有医疗环境中共同决策的内部和外部影响进行的定性系统评价。
JBI Libr Syst Rev. 2012;10(58):4633-4646. doi: 10.11124/jbisrir-2012-432.
3
Malaria Surveillance - United States, 2016.疟疾监测 - 美国,2016 年。
MMWR Surveill Summ. 2019 May 17;68(5):1-35. doi: 10.15585/mmwr.ss6805a1.
4
Atovaquone + proguanil: new preparation. Second-line antimalarial combination.阿托伐醌+氯胍:新制剂。二线抗疟联合用药。
Prescrire Int. 2002 Oct;11(61):131-6.
5
Perceptions of pharmacists' role in the health care team through student-pharmacist led point-of-care screenings and its future application in health care.通过学生药剂师主导的即时护理筛查对药剂师在医疗团队中角色的认知及其在医疗保健中的未来应用。
Curr Pharm Teach Learn. 2017 Mar-Apr;9(2):195-200. doi: 10.1016/j.cptl.2016.11.007.
6
Atovaquone and proguani hydrochloride compared with chloroquine or pyrimethamine/sulfodaxine for treatment of acute Plasmodium falciparum malaria in Peru.在秘鲁,阿托伐醌和盐酸氯胍与氯喹或乙胺嘧啶/磺胺多辛治疗急性恶性疟原虫疟疾的比较。
Braz J Infect Dis. 2001 Apr;5(2):67-72. doi: 10.1590/s1413-86702001000200004.
7
Atovaquone and proguanil hydrochloride for prophylaxis of malaria.阿托伐醌和盐酸氨丙啉用于疟疾预防。
J Travel Med. 1999 May;6 Suppl 1:S21-7.
8
Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group.malarone(阿托伐醌与盐酸氯胍):关于其治疗疟疾临床开发情况的综述。malarone临床试验研究组。
Am J Trop Med Hyg. 1999 Apr;60(4):533-41. doi: 10.4269/ajtmh.1999.60.533.
9
Atovaquone and proguanil hydrochloride: a review of nonclinical studies.阿托伐醌和盐酸氨丙啉:非临床研究综述。
J Travel Med. 1999 May;6 Suppl 1:S8-12.
10
Atovaquone and proguanil hydrochloride for treatment of malaria.阿托伐醌和盐酸氨苯砜用于疟疾治疗。
J Travel Med. 1999 May;6 Suppl 1:S18-20.

引用本文的文献

1
Science's Response to CoVID-19.科学应对新冠病毒。
ChemMedChem. 2021 Aug 5;16(15):2288-2314. doi: 10.1002/cmdc.202100079. Epub 2021 Jun 22.
2
Journalistic Denial of Death during the Very First Traumatic Period of the Italian COVID-19 Pandemic.意大利新冠疫情首个创伤期内新闻界对死亡的否认
Behav Sci (Basel). 2021 Mar 23;11(3):41. doi: 10.3390/bs11030041.

本文引用的文献

1
US Hydroxychloroquine, Chloroquine, and Azithromycin Outpatient Prescription Trends, October 2019 Through March 2020.美国羟氯喹、氯喹和阿奇霉素门诊处方趋势,2019 年 10 月至 2020 年 3 月。
JAMA Intern Med. 2020 Oct 1;180(10):1384-1386. doi: 10.1001/jamainternmed.2020.2594.
2
Prescription Fill Patterns for Commonly Used Drugs During the COVID-19 Pandemic in the United States.美国 COVID-19 大流行期间常用药物的处方配药模式。
JAMA. 2020 Jun 23;323(24):2524-2526. doi: 10.1001/jama.2020.9184.
3
The Risks of Prescribing Hydroxychloroquine for Treatment of COVID-19-First, Do No Harm.开具羟氯喹治疗新冠病毒病的风险——首先,不要造成伤害。
JAMA Intern Med. 2020 Aug 1;180(8):1118-1119. doi: 10.1001/jamainternmed.2020.1853.
4
A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19.仓促下结论?有关羟氯喹治疗 COVID-19 的快速报告和结果传播及其后果。
Ann Intern Med. 2020 Jun 16;172(12):819-821. doi: 10.7326/M20-1223. Epub 2020 Mar 30.
5
A method for estimating the probability of adverse drug reactions.一种估算药物不良反应概率的方法。
Clin Pharmacol Ther. 1981 Aug;30(2):239-45. doi: 10.1038/clpt.1981.154.

新冠疫情相关的媒体误导:一则病例报告凸显媒体对患者用药决策的影响

Covid Media Misguidance: A Case Report Highlighting the Influence of Media on Patient Medication Decision Making.

作者信息

Anderson Shaylee, Windscheffel Joe, Gunning Karen

机构信息

University of Utah College of Pharmacy.

University of Utah Health.

出版信息

Innov Pharm. 2021 Jan 8;12(1). doi: 10.24926/iip.v12i1.3555. eCollection 2021.

DOI:10.24926/iip.v12i1.3555
PMID:34007686
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8102979/
Abstract

PURPOSE

This case report details the influence of media on patients and the responsibility of health care providers to educate their patients on proper use of medications, and to be aware of potential misadventures based on messages in popular media.

SUMMARY

The sudden rise of the COVID19 pandemic has led to media outlets reporting science without necessary peer review and has resulted in preliminary data presented as factual evidence. It is difficult for patients without an extensive medical background in science to fully understand the uncertainty of information shared in popular media. This was demonstrated when preliminary data showed potential promise of hydroxychloroquine for the treatment/prevention of COVID19. This led to patients requesting hydroxychloroquine prescriptions from their providers, as well as stockpiling medication, which led to a shortage. In addition, patients began taking chloroquine containing substances not intended for human consumption. Popular media created a belief in the general public that all antimalarial drugs may work to prevent COVID19. This case report presents an elderly patient that presented to clinic with shortness of breath and lightheadedness. Upon interviewing the patient, it was discovered that he had been taking an old supply of atovaquone and proguanil hydrochloride. Physical exam, and laboratory examination were evaluated to rule out any other etiology with all tests and exams being unremarkable. Two weeks after stopping atovaquone and proguanil hydrochloride, the patient's symptoms completely resolved.

CONCLUSION

The media provides a significant portion of the information that patients receive regarding rapidly changing treatment information in a pandemic. It is crucial for health care providers to know what information patients are exposed to, and to educate patients with evidence-based information. Pharmacists are the most accessible health care providers and have a key role in medication review and management. Educating patients on evidence-based use of medications may help avoid harm caused by misinformation from unreliable media sources.

摘要

目的

本病例报告详细阐述了媒体对患者的影响,以及医疗保健提供者有责任教育患者正确使用药物,并基于大众媒体中的信息意识到潜在的意外情况。

总结

新冠疫情的突然爆发导致媒体在未经必要同行评审的情况下报道科学内容,并将初步数据当作事实证据呈现。对于没有广泛科学医学背景的患者来说,很难完全理解大众媒体所分享信息的不确定性。这在初步数据显示羟氯喹对治疗/预防新冠有潜在前景时得到了体现。这导致患者向其医疗服务提供者索要羟氯喹处方,并囤积药物,进而造成了短缺。此外,患者开始服用含氯喹但并非供人食用的物质。大众媒体使公众相信所有抗疟药物都可能对预防新冠有效。本病例报告介绍了一名因呼吸急促和头晕到诊所就诊的老年患者。在询问患者时,发现他一直在服用旧的阿托伐醌和盐酸氯胍。进行了体格检查和实验室检查以排除任何其他病因,所有检查结果均无异常。在停用阿托伐醌和盐酸氯胍两周后,患者症状完全缓解。

结论

在疫情期间,媒体提供了患者所获取的关于快速变化的治疗信息的很大一部分。医疗保健提供者了解患者接触到的信息并以循证信息对患者进行教育至关重要。药剂师是最容易接触到的医疗保健提供者,在药物审查和管理中起着关键作用。教育患者循证用药可能有助于避免不可靠媒体来源的错误信息造成的危害。